Helicon Group Secures Exclusive China Rights For Collatamp G, An Innovative Drug Release Surgical Implant

May 12, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Perth, May 12, 2008 (ABN Newswire) - HELICON GROUP LIMITED (ASX: HCG) announced today that it had acquired the exclusive licensing rights from EUSA Pharma to Collatamp(R) G for the Chinese market.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Australia